LIVIVO - Search results -

Search results

Result 1 - 10 of total 86

Search options

Article ; Online: HIV infection in the setting of PrEP: Development of antiretroviral resistance and breakthrough infection. Report of two cases in real-life.

Chivite, Ivan / Riera-Monroig, Josep / Ambrosioni, Juan / Laguno, Montserrat

Enfermedades infecciosas y microbiologia clinica (English ed.)

2022 Volume 40, Issue 5, Page(s) 280–281

MeSH term(s)	Anti-HIV Agents/therapeutic use ; Anti-Retroviral Agents/therapeutic use ; HIV Infections/complications ; HIV Infections/drug therapy ; Humans
Chemical Substances	Anti-HIV Agents ; Anti-Retroviral Agents
Language	English
Publishing date	2022-05-14
Publishing country	Spain
Document type	Case Reports
ISSN	2529-993X
ISSN (online)	2529-993X
DOI	10.1016/j.eimce.2021.11.009
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Reply to: "Do we promote pre-exposition prophylaxis in the emergency service?"

Laguno, Montserrat / Ugarte, Ainoa / Martinez-Rebollar, María / de Lazzari, Elisa / Mallolas, Josep

Enfermedades infecciosas y microbiologia clinica (English ed.)

2023 Volume 41, Issue 7, Page(s) 449–450

MeSH term(s)	Humans ; HIV Infections/drug therapy ; Anti-HIV Agents/therapeutic use
Chemical Substances	Anti-HIV Agents
Language	English
Publishing date	2023-05-27
Publishing country	Spain
Document type	Letter ; Comment
ISSN	2529-993X
ISSN (online)	2529-993X
DOI	10.1016/j.eimce.2023.05.004
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide-induced cholestasis.

Ugarte, Ainoa / De la Mora, Lorena / Martínez-Rebollar, María / Mallolas, Josep / Laguno, Montserrat

Antiviral therapy

2021 Volume 26, Issue 1-2, Page(s) 9–12

MeSH term(s)	Alanine ; Anti-HIV Agents/adverse effects ; Cholestasis ; Cobicistat/adverse effects ; Emtricitabine/adverse effects ; Humans ; Quinolones ; Tenofovir/analogs & derivatives
Chemical Substances	Anti-HIV Agents ; Quinolones ; elvitegravir (4GDQ854U53) ; Tenofovir (99YXE507IL) ; tenofovir alafenamide (EL9943AG5J) ; Emtricitabine (G70B4ETF4S) ; Cobicistat (LW2E03M5PG) ; Alanine (OF5P57N2ZX)
Language	English
Publishing date	2021-09-20
Publishing country	England
Document type	Journal Article
ZDB-ID	1339842-8
ISSN	2040-2058 ; 1359-6535
ISSN (online)	2040-2058
ISSN	1359-6535
DOI	10.1177/13596535211045832
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4877: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 174: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations.

Inciarte, Alexy / de la Mora, Lorena / Huaier-Arriazu, Emilio / Torres, Berta / Cañizares, Silvia / Zamora, Elizabeth / Laguno, Montserrat / Gonzalez-Cordón, Ana / Foncillas, Alberto / Chivite, Ivan / Calvo, Júlia / Ambrosioni, Juan / Martínez, Esteban / Blanco, Jose Luis / Miro, J M / Martinez-Rebollar, Maria / Mallolas, Josep

Infectious diseases and therapy

2024 Volume 13, Issue 4, Page(s) 647–658

Abstract: Background: A broadened clinical spectrum of concomitant complications emerges among the escalating incidence of substance use, particularly within the 'chemsex' context. This case exemplifies the profound neurotoxic repercussions and neurological risk ... ...

Abstract	Background: A broadened clinical spectrum of concomitant complications emerges among the escalating incidence of substance use, particularly within the 'chemsex' context. This case exemplifies the profound neurotoxic repercussions and neurological risk of chemsex in a young HIV-positive male and addresses the multifaceted challenges of such evolving paradigms in substance utilization. Clinical finding: After consuming cannabis, poppers, methamphetamine, and cocaine, a 28-year-old HIV-positive male exhibited significant neurological and cognitive impairment. The initial presentation included dysarthria and profound anterograde amnesia. Laboratory findings showed leukocytosis with a PCR of 3 mg/dl - elevated cerebrospinal fluid protein levels with no cells. Urine toxicology returned positive for cannabis and amphetamines. A brain CT scan revealed bilateral and symmetrical hippocampi and pale globes hypodensity, indicative of toxic-metabolic encephalopathy. MRI further identified lesions in the globus pallidus, cerebellum, and hippocampi. Following the detection of toxic encephalopathy, Initial neuropsychological was performed screening using the Montreal Cognitive Assessment (MoCA), which highlighted immediate memory deficits. An in-depth neuropsychological assessment conducted 3 weeks later included the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV), the Rey Auditory Verbal Learning Test (RAVLT), and tests for visuospatial skills, motor functions, and memory recall. The evaluations revealed pronounced anterograde amnesia, persistent long-term memory inconsistencies, and notable executive function challenges, detailed in Table 1. Conclusions: The detailed analysis of this case underpins the severe neurological consequences that can manifest from heavy substance use. Comprehensive diagnostic evaluations, including neuroimaging and neuropsychological assessments, are crucial in elucidating the full spectrum of substance-induced cognitive impairments. There is an urgent need for enhanced public awareness and preventative measures, especially in the context of chemsex, to bring forth multifaceted health, social, and government implications that modern society must adeptly navigate.
Language	English
Publishing date	2024-04-03
Publishing country	New Zealand
Document type	Journal Article
ZDB-ID	2701611-0
ISSN	2193-6382 ; 2193-8229
ISSN (online)	2193-6382
ISSN	2193-8229
DOI	10.1007/s40121-024-00962-x
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Primary HIV-1 infection in users of pre-exposure prophylaxis.

Ambrosioni, Juan / Petit, Elisa / Liegeon, Geoffroy / Laguno, Montserrat / Miró, José M

The lancet. HIV

2020 Volume 8, Issue 3, Page(s) e166–e174

Abstract: Pre-exposure prophylaxis (PrEP) has proven to be a highly effective and safe way to prevent HIV infection. Seroconversion and primary HIV infection are exceptional if adherence to PrEP is good. However, primary HIV infection while using PrEP can occur, ... ...

Abstract	Pre-exposure prophylaxis (PrEP) has proven to be a highly effective and safe way to prevent HIV infection. Seroconversion and primary HIV infection are exceptional if adherence to PrEP is good. However, primary HIV infection while using PrEP can occur, albeit rarely, and HIV drug resistance might develop. Furthermore, the scope of PrEP is expected to expand, and clinicians might face potential seroconversions and primary HIV infection in patients starting or taking PrEP. The characteristics of primary HIV infection in users of PrEP are poorly described. PrEP users present a lower viral load peak during primary HIV infection and, frequently, fewer symptoms than individuals not exposed to PrEP. Additionally, PrEP prolongs the stages of seroconversion, thus potentially complicating diagnosis of primary HIV infection. Drug resistance is rare, occurring mostly when PrEP is initiated in undiagnosed patients who are at an extremely early stage of infection, in whom detection of HIV-RNA was not used to rule out HIV infection. Therefore, careful exclusion of primary HIV infection before starting PrEP is crucial. In patients presenting with primary HIV infection while on PrEP, a drug with a high genetic barrier (or even two) should be added to tenofovir disoproxil fumarate-emtricitabine until test results for resistance are available.
MeSH term(s)	Emtricitabine/therapeutic use ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; HIV Infections/drug therapy ; HIV Infections/prevention & control ; HIV Seropositivity ; HIV-1/drug effects ; Humans ; Pre-Exposure Prophylaxis/methods ; Tenofovir/therapeutic use ; Viral Load/drug effects
Chemical Substances	Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination ; Tenofovir (99YXE507IL) ; Emtricitabine (G70B4ETF4S)
Language	English
Publishing date	2020-12-11
Publishing country	Netherlands
Document type	Journal Article ; Research Support, Non-U.S. Gov't ; Review
ISSN	2352-3018
ISSN (online)	2352-3018
DOI	10.1016/S2352-3018(20)30271-X
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: About "Executive summary of the GeSIDA consensus document on control and monitoring of HIV-infected patients".

Modesto Dos Santos, Joao Luis / Laguno, Montserrat / Inciarte, Alexy / González-Cordón, Ana

Enfermedades infecciosas y microbiologia clinica (English ed.)

2020 Volume 38, Issue 6, Page(s) 299–300

MeSH term(s)	Anti-HIV Agents/therapeutic use ; Antiretroviral Therapy, Highly Active ; Consensus ; HIV Infections/drug therapy ; Humans
Chemical Substances	Anti-HIV Agents
Language	Spanish
Publishing date	2020-01-10
Document type	Letter ; Comment
ISSN	2529-993X
ISSN (online)	2529-993X
DOI	10.1016/j.eimc.2019.12.006
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital.

Aguilera, Paula / Laguno, Montserrat / To-Figueras, Jordi

Photodermatology, photoimmunology & photomedicine

2016 Volume 32, Issue 2, Page(s) 93–97

Abstract: Background: Human immunodeficiency virus (HIV) infection has been reported to be a risk factor for porphyria cutanea tarda (PCT).: Purpose: To assess the strength of the association between HIV infection and PCT in a large hospital setting.: ... ...

Abstract	Background: Human immunodeficiency virus (HIV) infection has been reported to be a risk factor for porphyria cutanea tarda (PCT). Purpose: To assess the strength of the association between HIV infection and PCT in a large hospital setting. Methods: All patients (N = 210) diagnosed of PCT between 1990 and 2014 were retrospectively investigated for HIV infection and co-precipitating factors. High-performance liquid chromatography was used to assess the appearance of pre-PCT urinary porphyrin abnormalities among a group (N = 22) of HIV-infected patients without PCT using the urine of patients co-infected with hepatitis C virus (HCV) without PCT for comparison. Results: Twenty-six HIV-infected patients (19 males and seven females) were diagnosed of PCT. During the same interval of time, ~8000 different patients infected with HIV were attended in the hospital of infectious diseases department. Examination of risk factors showed that 25 out of 26 of the PCT patients with HIV were co-infected with HCV. No chromatographic abnormalities were found in the urine of non-PCT-HIV-infected patients, whereas 39% co-infected patients showed urinary porphyrin abnormalities. Conclusions: In our large hospital series, the appearance of PCT among HIV-infected patients is low (<1%) and most present co-infection with HCV. Therefore, in most HIV-infected patients with PCT, hepatitis C and not HIV may induce uroporphyrinogen decarboxylase deficiency.
MeSH term(s)	Adult ; Female ; HIV Infections/complications ; HIV Infections/urine ; HIV-1 ; Humans ; Male ; Middle Aged ; Porphyria Cutanea Tarda/etiology ; Porphyria Cutanea Tarda/urine ; Porphyrins/urine
Chemical Substances	Porphyrins
Language	English
Publishing date	2016-03
Publishing country	England
Document type	Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	1028855-7
ISSN	1600-0781 ; 0108-9684 ; 0905-4383
ISSN (online)	1600-0781
ISSN	0108-9684 ; 0905-4383
DOI	10.1111/phpp.12222
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1951: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study.

de Lazzari, Elisa / Berrocal, Leire / Fernández, Emma / Laguno, Montserrat / Chivite, Iván / Torres, Berta / González-Cordón, Ana / de la Mora, Lorena / Ambrosioni, Juan / Iniciarte, Alexy / Blanco, José Luís / Miró, Josep Maria / Martínez, Esteban / Martínez-Rebollar, Maria / Mallolas, Josep

Medicine

2023 Volume 102, Issue 14, Page(s) e33442

Abstract: Human immunodeficiency virus (HIV) infection is considered a chronic disease. Antiretroviral therapy has allowed persons with HIV (PLWHIV) to achieve the 90-90-90 objectives proposed by the World Health Organization for 2020; but an additional challenge ... ...

Abstract	Human immunodeficiency virus (HIV) infection is considered a chronic disease. Antiretroviral therapy has allowed persons with HIV (PLWHIV) to achieve the 90-90-90 objectives proposed by the World Health Organization for 2020; but an additional challenge is getting an adequate health-related quality of life. A determining factor in the health-related quality of life of PLWHIV is the health care they perceive to receive. In this sense, we aimed to assess the perception of the outpatient care provided and to identify possible areas for improvement in a single-center, cross-sectional study at the HIV unit of Hospital Clínic, Barcelona. We sought patient reported experience measures by an anonymous e-survey with 11 statements based on a 1 to 6 Likert scale, and a final question measuring user satisfaction and loyalty through the Net Promoter Score (NPS). All PLWHIV with at least a clinical visit between January 1, 2020 and October 14, 2021 were invited. Of 5493 PLWHIV e-mailed, 1633 (30%) responded to the survey. The overall evaluation of clinical care was very favorable. The evaluation of the physical environment and facilities and the time spent in the waiting room received the lowest scores. According to the Net Promoter Score test results, 66% of respondents were willing to recommend this service, and 11% were not. Thus, monitoring patient reported experience measures in PLWHIV actively receiving outpatient care in our hospital allowed to identify the users' perception on quality of the care received, to determine the rate of satisfaction with the care, and to identify areas for improvement.
MeSH term(s)	Adult ; Humans ; Cross-Sectional Studies ; Quality of Life ; HIV Infections/drug therapy ; Perception ; Patient Reported Outcome Measures ; Patient Satisfaction
Language	English
Publishing date	2023-04-07
Publishing country	United States
Document type	Journal Article
ZDB-ID	80184-7
ISSN	1536-5964 ; 0025-7974
ISSN (online)	1536-5964
ISSN	0025-7974
DOI	10.1097/MD.0000000000033442
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.171: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiation.

Chalouni, Mathieu / Trickey, Adam / Ingle, Suzanne M / Sepuvelda, Maria Antonia / Gonzalez, Juan / Rauch, Andri / Crane, Heidi M / Gill, M John / Rebeiro, Peter F / Rockstroh, Jürgen K / Franco, Ricardo A / Touloumi, Giota / Neau, Didier / Laguno, Montserrat / Rappold, Michaela / Smit, Colette / Sterne, Jonathan A C / Wittkop, Linda

AIDS (London, England)

2023 Volume 37, Issue 10, Page(s) 1573–1581

Abstract: Objective: Hepatitis C virus (HCV) co-infection is associated with increased morbidity and mortality in people with HIV (PWH). Sustained virological response (SVR) decreases the risk of HCV-associated morbidity. We compared mortality, risk of AIDS- ... ...

Abstract	Objective: Hepatitis C virus (HCV) co-infection is associated with increased morbidity and mortality in people with HIV (PWH). Sustained virological response (SVR) decreases the risk of HCV-associated morbidity. We compared mortality, risk of AIDS-defining events, and non-AIDS nonliver (NANL) cancers between HCV-co-infected PWH who reached SVR and mono-infected PWH. Design: Adult PWH from 21 cohorts in Europe and North America that collected HCV treatment data were eligible if they were HCV-free at the time of ART initiation. Methods: Up to 10 mono-infected PWH were matched (on age, sex, date of ART start, HIV acquisition route, and being followed at the time of SVR) to each HCV-co-infected PWH who reached SVR. Cox models were used to estimate relative hazards (hazard ratio) of all-cause mortality, AIDS-defining events, and NANL cancers after adjustment. Results: Among 62 495 PWH, 2756 acquired HCV, of whom 649 reached SVR. For 582 of these, at least one mono-infected PWH could be matched, producing a total of 5062 mono-infected PWH. The estimated hazard ratios comparing HCV-co-infected PWH who reached SVR with mono-infected PWH were 0.29 [95% confidence interval (CI) 0.12-0.73] for mortality, 0.85 [0.42-1.74] for AIDS-defining events, and 1.21 [0.86-1.72] for NANL cancer. Conclusion: PWH who reached SVR a short time after HCV acquisition were not at higher risk of overall mortality compared with mono-infected PWH. However, the apparent higher risk of NANL cancers in HCV-co-infected PWH who reached SVR after a DAA-based treatment compared with mono-infected PWH, though compatible with a null association, suggests a need for monitoring of those events following SVR.
MeSH term(s)	Adult ; Humans ; HIV Infections/complications ; HIV Infections/drug therapy ; Hepacivirus ; Antiviral Agents/therapeutic use ; Treatment Outcome ; Hepatitis C/complications ; Hepatitis C/drug therapy ; Morbidity ; Hepatitis C, Chronic/complications ; Coinfection
Chemical Substances	Antiviral Agents
Language	English
Publishing date	2023-05-09
Publishing country	England
Document type	Journal Article
ZDB-ID	639076-6
ISSN	1473-5571 ; 0269-9370 ; 1350-2840
ISSN (online)	1473-5571
ISSN	0269-9370 ; 1350-2840
DOI	10.1097/QAD.0000000000003594
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2228: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study.

Martínez-Serra, Adrián / De Lazzari, Elisa / Berrocal, Leire / Foncillas, Alberto / De La Mora, Lorena / Inciarte, Alexy / Chivite, Iván / González-Cordón, Ana / Martínez-Rebollar, María / Torres, Berta / Laguno, Montserrat / Blanco, José Luis / Martínez, Esteban / Mallolas, Josep / Ambrosioni, Juan

The Journal of antimicrobial chemotherapy

2023 Volume 78, Issue 8, Page(s) 1955–1962

Abstract: Background: The use of dolutegravir/lamivudine is based on solid clinical trials; however, real-world data remain limited.: Objectives: To provide data on the clinical use and effectiveness of dolutegravir/lamivudine in persons with HIV in a real- ... ...

Abstract	Background: The use of dolutegravir/lamivudine is based on solid clinical trials; however, real-world data remain limited. Objectives: To provide data on the clinical use and effectiveness of dolutegravir/lamivudine in persons with HIV in a real-world scenario. Patients and methods: Retrospective, single-centre and observational study. We included all adults starting dolutegravir/lamivudine since November 2014. We reported all demographic, virological and immunological variables at baseline and assessed effectiveness [on treatment (OT), modified ITT (mITT) and ITT in those persons who reached 6 and 12 month follow-ups (M6 and M12). Results: Of the 1058 persons, 9 were treatment-naive; the final analysis included 1049 treatment-experienced people with HIV. Median (IQR) follow-up was 1 (0.3-1.6) years, with 81% and 63% persons reaching M6 and M12, respectively. The longest use of dolutegravir/lamivudine was 7.4 years. Per OT, mITT and ITT, HIV-RNA < 50 copies/mL was 97%, 92% and 81% (M6) and 98%, 90% and 80% (M12), respectively. Females [adjusted risk ratio, aRR (95% CI): 1.69 (1.19-2.40)]; immediate, previous PI-based regimen [aRR (95% CI): 1.67 (1.09-2.56)]; and viral load (VL) ≥ 50 copies/mL at dolutegravir/lamivudine initiation [aRR (95% CI): 3.36 (2.32-4.88)] were independently associated with lack of effectiveness at M12; other demographic, immunological and virological variables like previous M184V/I substitutions or virological failure, were unrelated. Of the total, 944 (90%) continued dolutegravir/lamivudine. The most frequent known reason for discontinuation was toxicity [48 (46%) cases]. Conclusions: In our real-world experience, virological suppression rates were high for treatment-experienced persons on dolutegravir/lamivudine; however, we identified subgroups with a higher risk of lack of effectiveness at M12, who may benefit from closer follow-ups.
MeSH term(s)	Adult ; Female ; Humans ; Lamivudine/therapeutic use ; Retrospective Studies ; HIV Infections/drug therapy ; Anti-HIV Agents/therapeutic use ; Drug Therapy, Combination ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Oxazines/therapeutic use ; Pyridones/therapeutic use
Chemical Substances	Lamivudine (2T8Q726O95) ; dolutegravir (DKO1W9H7M1) ; Anti-HIV Agents ; Heterocyclic Compounds, 3-Ring ; Oxazines ; Pyridones
Language	English
Publishing date	2023-06-13
Publishing country	England
Document type	Observational Study ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	191709-2
ISSN	1460-2091 ; 0305-7453
ISSN (online)	1460-2091
ISSN	0305-7453
DOI	10.1093/jac/dkad189
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1197: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 124: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito